Survey on the Pharmacy Follow-up of Alli Purchasers
Survey on the Pharmacy Follow up of Alli Purchasers
1 other identifier
observational
80
0 countries
N/A
Brief Summary
To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2010
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 29, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Posted
Study publicly available on registry
July 4, 2011
CompletedOctober 29, 2012
October 1, 2012
11 months
March 29, 2010
October 25, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Physical activity
baseline to 1 year
Secondary Outcomes (3)
Change in dietary behavior
baseline to 1 year
Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)
baseline to 1 year
Satisfaction with management (i.e., results on weight and treatment comfort)
baseline to 1 year
Study Arms (1)
60 mg Orlistat
Purchased by consumer
Interventions
Eligibility Criteria
Consumers purchasing orlistat in a pharmacy setting
You may qualify if:
- Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
GlaxoSmithKline
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2010
First Posted
July 4, 2011
Study Start
January 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
October 29, 2012
Record last verified: 2012-10